Ozempic shortages in the EU will not affect all Member States
An intermittent shortage of the diabetes drug Ozempic in the European Union, which is expected to persist into the last quarter of 2024 due to high demand, will not affect all member states, Danish pharmaceutical company Novo Nordisk said.
ENTRADAS POPULARES
Putin may discuss Ukraine peace deal with Trump
noviembre 22, 2024
Spain’s vice-president Ribera blames floods on climate change
noviembre 22, 2024
Storm lashes northwestern US, killing two people
noviembre 22, 2024
Iceland volcano erupts for tenth time in three years
noviembre 22, 2024
TRANSMISIÓN EN VIVO